Cymevene (ganciclovir): Reviews and patient testimonials
Medication indications
Cymevene 500 mg powder for concentrate for solution for Infusion
Cymevene is indicated in adults and adolescents from 12 years of age for the:
- treatment of cytomegalovirus (CMV) disease in immunocompromised patients;
- prevention of CMV disease in patients with drug-induced immunosuppression (for example following organ transplantation or cancer chemotherapy).
Consideration should be given to official guidance on the appropriate use of antiviral agents.
Route of administration: Injectable
Molecule: ganciclovir
Patients' opinions on Cymevene
In brief
General satisfaction level: Be the first to evaluate
Treatment's effectiveness: Be the first to evaluate
Ease of use: Be the first to evaluate
Adherence to prescription: Be the first to evaluate
Detected side effects: Be the first to evaluate
Improvement in the quality of life: Be the first to evaluate
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Never
10 = Always
1 = Not at all important
10 = Extremely important
1 = Not at all satisfied
10 = Extremely satisfied
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.